Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
Balsalazide is a prodrug form of 5-aminosalicylic acid (5-ASA; Item No. 70265).1 It is cleaved by bacterial azoreductases in the intestinal lumen to release 5-ASA. Balsalazide (600 mg/kg per day) decreases IL-2 levels and increases IL-6 levels in the serum and colonic mucosa membrane, as well as decreases micro- and macroscopic colonic damage, in a rat model of colitis induced by 2,4-dinitrochlorobenzene (DNCB).2 Formulations containing balsalazide have been used in the treatment of ulcerative colitis.
WARNING This product is not for human or veterinary use.
1. Balsalazide in treating colonic diseases. Expert Opin. Drug Metab. Toxicol. 5(12), 1555-1563 (2009).
2. Effects of balsalazide on experimental colitis induced by 2,4-